Clinical trials for Cancer in United States

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

Study ID: NCT06634394

Sponsor

Aptevo Therapeutics

A Study of Intra-operative Imaging in Women With Ovarian Cancer

Study ID: NCT04878094

Sponsor

Memorial Sloan Kettering Cancer Center

First In Human Study of CX-801 in Advanced Solid Tumors

Study ID: NCT06462794

Sponsor

CytomX Therapeutics

Pan-tumor MRD Study

Study ID: NCT06605404

Sponsor

Flatiron Health

Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

Study ID: NCT06047301

Sponsor

Laurie McLouth

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

Study ID: NCT04474301

Sponsor

M.D. Anderson Cancer Center

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Study ID: NCT04370301

Sponsor

Fred Hutchinson Cancer Center

Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma

Study ID: NCT04580667

Sponsor

Diacarta, Inc.

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

Study ID: NCT04797767

Sponsor

University of Washington

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Study ID: NCT06109467

Sponsor

H. Lee Moffitt Cancer Center and Research Institute